As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader

Pharma regime shifts have become the norm this month as outfits such as Biogen and Seagen wrapped up monthslong searches for new chief executives. For generics juggernaut Teva Pharmaceutical, however, the hunt has ended sooner than expected, with a new helmsman waiting in the wings mere weeks after the company revealed its mission to replace current top executive Kåre Schultz.